Mark J Gergen Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark J Gergen.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark J Gergen. Mark J Gergen is Sr VP Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP, Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Operating Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Executive VP, COO in Mirati Therapeutics, Inc. ($MYG) and President and CBO in Poseida Therapeutics, Inc. ($PSTX).

Mark J Gergen in HALOZYME THERAPEUTICS, INC.

Trading Symbol: GYHT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark J Gergen: SVP, Chief Operating Officer
Holdings: 0 shares
Latest Transaction: Sep 02 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mark J Gergen in HALOZYME THERAPEUTICS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMLN, GYHT, MYG, PSTX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 02 2016GYHTHALOZYME THERAPEUT ...Gergen Mark JSVP, Chief Operatin ...Option ExerciseA9.97333,8903,328,883333,890

Page:   1